Authors
Loading...
Analysis shows enhanced tumor immune microenvironment in cancer driven by DNMT3A clonal hematopoiesis, suggesting strategies against inflammation-related cancers.
Kaur et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: